abstract |
The invention discloses a biomarker and application thereof in cerebral infarction diagnosis, and particularly discloses a biomarker PC (14:0/18:2(9Z,12Z)), wherein the level of cerebral infarction of the biomarker PC (14:0/18:2(9Z,12Z)) is reduced compared with that of a healthy control, and the biomarker PC (14:0/18:2(9Z,12Z)) is used as a detection variable, so that the biomarker has higher efficiency of distinguishing the cerebral infarction from the healthy control. |